Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

Oct 24, 2024

- Oct 23, 2025

0.75

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians

The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosi...

Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis